Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 28, 2010

Repligen Strikes Five-Year Extension to Supply Protein A to GE Healthcare

  • Repligen entered into a five-year supply agreement with GE Healthcare for recombinant Protein A, a consumable used in the manufacture of mAbs. This agreement provides for Repligen to continue to be a strategic supplier to GE Healthcare through 2014.

    GE Healthcare sells chromatography products that incorporate Repligen's recombinant Protein A to the biopharmaceutical industry for the manufacture of mAbs.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »